Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
ALEMTUZUMAB
Lemtrada
Multiple Sclerosis
LPS13650EMERALDEudraCT: 2014-000092-62Tabulated Results
ALEMTUZUMAB
Lemtrada
Multiple Sclerosis
OBS13436NANCT03774914Abstract
ALEMTUZUMAB
Not Marketed
Multiple Sclerosis
TDU13475NANCT02282826Summary
ALEMTUZUMAB
Lemtrada
Multiple Sclerosis
TDU14260SCALANCT02583594Summary
ALEMTUZUMAB
Not Marketed
Multiple Sclerosis
TDU14981NANCT02977533Summary
ALFUZOSIN
Uroxatral, Xatral
Prostatic Diseases
ALFUS_L_01241SAMBA_THAILANDNCT00401661Summary
ALFUZOSIN
Uroxatral, Xatral
Prostatic Diseases
ALFUS_L_01667SAMBANCT00486785Summary
ALFUZOSIN
Uroxatral, Xatral
Benign Prostatic Hyperplasia
DRI5234NANCT00409357Summary
ALFUZOSIN
Uroxatral, Xatral
Benign Prostatic Hyperplasia
EFC4428ALFAURUSNCT00290030Summary
ALFUZOSIN
Uroxatral, Xatral
Benign Prostatic Hyperplasia
EFC4485NANCT00029822Publication's reference

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted